Whales with a lot of money to spend have taken a noticeably bullish stance on Moderna.
Looking at options history for Moderna MRNA we detected 12 trades.
If we consider the specifics of each trade, it is accurate to state that 41% of the investors opened trades with bullish expectations and 41% with bearish.
From the overall spotted trades, 8 are puts, for a total amount of $322,262 and 4, calls, for a total amount of $261,450.
Predicted Price Range
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $50.0 to $120.0 for Moderna during the past quarter.
Insights into Volume & Open Interest
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Moderna's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Moderna's substantial trades, within a strike price spectrum from $50.0 to $120.0 over the preceding 30 days.
Moderna Option Activity Analysis: Last 30 Days
Largest Options Trades Observed:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRNA | CALL | TRADE | BEARISH | 01/17/25 | $20.5 | $20.0 | $20.0 | $115.00 | $90.0K | 579 | 45 |
| MRNA | CALL | TRADE | BULLISH | 01/16/26 | $40.95 | $38.35 | $40.25 | $100.00 | $80.5K | 587 | 20 |
| MRNA | CALL | TRADE | NEUTRAL | 01/17/25 | $65.25 | $63.75 | $64.5 | $50.00 | $64.5K | 54 | 10 |
| MRNA | PUT | SWEEP | NEUTRAL | 05/03/24 | $3.2 | $2.58 | $2.91 | $109.00 | $58.1K | 270 | 212 |
| MRNA | PUT | SWEEP | BEARISH | 05/10/24 | $4.1 | $4.05 | $4.1 | $110.00 | $52.0K | 161 | 52 |
About Moderna
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Where Is Moderna Standing Right Now?
- Trading volume stands at 1,451,086, with MRNA's price down by -0.95%, positioned at $110.56.
- RSI indicators show the stock to be may be approaching overbought.
- Earnings announcement expected in 2 days.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Moderna, Benzinga Pro gives you real-time options trades alerts.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
